Injective (INJ) is currently trading at $3.74, reflecting a slight decline of 0.81% over the last 24 hours. The daily price range has been relatively narrow, with a high of $3.89 and a low of $3.72, indicating subdued volatility in the market.

The trading volume stands at approximately 66.56 million, representing 17.79% of its market cap, which suggests a moderate level of investor interest. The hourly moving averages indicate bearish momentum, with the 8, 13, and 21 SMAs all showing negative trends, while the longer 55 and 144 SMAs are indicating slight bullish momentum.

The 1-hour RSI of 40 suggests that INJ is approaching oversold conditions, while the 7-day RSI of 48 indicates a neutral stance. Over the last 30 days, INJ has shown a robust price increase of over 33%, reflecting positive longer-term momentum despite current short-term fluctuations.

The all-time high for INJ remains significantly above the current price at $52.62, suggesting substantial potential upside if the market recovers. However, the recent price action and technical indicators indicate that a corrective phase may still be underway.

Given the current market conditions, the technical indicators suggest a cautious approach. The mixed signals from the moving averages and RSI metrics imply that while there may be potential for recovery, short-term pressures could persist.

Rating: Hold. The prevailing bearish indicators in the short term recommend waiting for confirmation of upward momentum before initiating new positions.